Bolelli L, Bobrovová Z, Ferri E, Fini F, Menotta S, Scandurra S, Fedrizzi G, Girotti S
Istituto Scienze Chimiche, University of Bologna, Via S. Donato 15, 40127 Bologna, Italy.
J Pharm Biomed Anal. 2006 Sep 11;42(1):88-93. doi: 10.1016/j.jpba.2005.12.034. Epub 2006 Feb 2.
The residues of pharmacological treatments on food-producing animals, present in the manure dispersed on agricultural land, can impact environmental and human health through toxic, genotoxic, and drug-resistance development effects. Biotoxicity assays can easily reveal the presence of noxious substances and those based on bioluminescent bacteria (BLB) are particularly simple and rapid. A BLB assay was developed as microplate format by using various strains of Vibrio sp. and was employed to evaluate their response to pure antibiotic solutions and to residues extracted from excreta of antibiotic treated pigs and turkeys. The residues were quantified by HPLC analysis. The BLB assay can be proposed as an easy-to-perform screening tool to assess the presence of residues due to undeclared current, or recently ended, pharmacological treatments, as well as to evaluate their permanence in manure.
用于食用动物的药物治疗残留存在于散布在农田中的粪便中,可通过毒性、遗传毒性和耐药性发展效应影响环境和人类健康。生物毒性测定可以很容易地揭示有害物质的存在,而基于生物发光细菌(BLB)的测定尤其简单快速。通过使用各种弧菌属菌株,开发了一种微孔板形式的BLB测定法,并用于评估它们对纯抗生素溶液以及从经抗生素治疗的猪和火鸡排泄物中提取的残留物的反应。残留物通过HPLC分析进行定量。BLB测定法可作为一种易于操作的筛选工具,用于评估由于当前未申报或最近结束的药物治疗而产生的残留物的存在,并评估它们在粪便中的持久性。